查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442895

与阿兹海默症相关的失智症市场 - 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Dementia Associated with Alzheimer's Disease Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 172 Pages | 商品交期: 2-10个工作天内

价格

与阿兹海默症市场相关的痴呆症 - 报告范围

TMR 关于与阿兹海默症相关的全球痴呆症市场的报告研究了过去以及当前的成长趋势和机会，以获得2023 年至2031 年预测期内市场指标的宝贵见解。该报告提供了全球痴呆症的收入与 2017-2031 年期间阿兹海默症市场相关，考虑 2023 年为基准年，2031 年为预测年。该报告还提供了2023年至2031年全球与阿兹海默症相关的痴呆症市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解与阿兹海默症相关的痴呆症市场。

该报告深入研究了与阿兹海默症相关的全球痴呆症市场的竞争格局。与阿兹海默症相关的全球痴呆症市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球失智症相关市场参与者的属性。

目录

第 1 章：执行摘要

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 市场区隔
  • 概述
  • 市场动态
  • 2017-2031 年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 全球主要国家的疾病盛行率和发生率
  • COVID-19 大流行对该行业的影响

第 6 章：市场分析与预测：依药品类别

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依药品类别，2017-2031
    • 胆碱能/胆碱酯酶 (ChE) 抑制剂
    • 美金刚
    • 联合药物（美金刚和多奈哌齐）
    • 其他的
  • 市场吸引力：按药品类别

第 7 章：全球市场分析与预测：按配销通路

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2017-2031
    • 医院药房
    • 零售
    • 网上销售
  • 市场吸引力：按配销通路

第 8 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 9 章：北美市场分析与预测

第 10 章：欧洲市场分析与预测

第 11 章：亚太市场分析与预测

第 12 章：拉丁美洲市场分析与预测

第 13 章：中东和非洲市场分析与预测

第 14 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Merz Pharma
    • Novartis AG
    • AbbVie Inc.
    • Pfizer, Inc.
    • Daiichi Sankyo Company, Limited.
    • Ono Pharmaceutical Co., Ltd.
    • Johnson & Johnson Services, Inc.
    • Eisai Co., Ltd.
    • H. Lundbeck A/S
    • F. Hoffmann-La Roche Ltd.
Product Code: TMRGL39203

Dementia Associated with Alzheimer's Disease Market - Scope of Report

TMR's report on the global dementia associated with Alzheimer's disease market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global dementia associated with Alzheimer's disease market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dementia associated with Alzheimer's disease market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the dementia associated with Alzheimer's disease market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dementia associated with Alzheimer's disease market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global dementia associated with Alzheimer's disease market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dementia associated with Alzheimer's disease market.

The report delves into the competitive landscape of the global dementia associated with Alzheimer's disease market. Key players operating in the global dementia associated with Alzheimer's disease market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global dementia associated with Alzheimer's disease market profiled in this report.

Key Questions Answered in Global dementia associated with Alzheimer's disease Market Report:

  • What is the sales/revenue generated by dementia associated with Alzheimer's disease across all regions during the forecast period?
  • What are the opportunities in the global dementia associated with Alzheimer's disease market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Dementia Associated with Alzheimer's Disease Market - Research Objectives and Research Approach

The comprehensive report on the global dementia associated with Alzheimer's disease market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global dementia associated with Alzheimer's disease market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global dementia associated with Alzheimer's disease market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Dementia Associated with Alzheimer's Disease Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Dementia Associated with Alzheimer's Disease Market Analysis and Forecasts, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Dementia Associated with Alzheimer's Disease Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Drug Class, 2017-2031
    • 6.3.1. Cholinergic/Cholinesterase (ChE) Inhibitors
    • 6.3.2. Memantine
    • 6.3.3. Combined Drugs (Memantine & Donepezil)
    • 6.3.4. Others
  • 6.4. Market Attractiveness, by Drug Class

7. Global Dementia Associated with Alzheimer's Disease Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail
    • 7.3.3. Online Sales
  • 7.4. Market Attractiveness, by Distribution Channel

8. Global Dementia Associated with Alzheimer's Disease Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2017-2031
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness, by Region

9. North America Dementia Associated with Alzheimer's Disease Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Drug Class, 2017-2031
    • 9.2.1. Cholinergic/Cholinesterase (ChE) Inhibitors
    • 9.2.2. Memantine
    • 9.2.3. Combined Drugs (Memantine & Donepezil)
    • 9.2.4. Others
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail
    • 9.3.3. Online Sales
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Drug Class
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country

10. Europe Dementia Associated with Alzheimer's Disease Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Drug Class, 2017-2031
    • 10.2.1. Cholinergic/Cholinesterase (ChE) Inhibitors
    • 10.2.2. Memantine
    • 10.2.3. Combined Drugs (Memantine & Donepezil)
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail
    • 10.3.3. Online Sales
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Drug Class
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Dementia Associated with Alzheimer's Disease Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Drug Class, 2017-2031
    • 11.2.1. Cholinergic/Cholinesterase (ChE) Inhibitors
    • 11.2.2. Memantine
    • 11.2.3. Combined Drugs (Memantine & Donepezil)
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail
    • 11.3.3. Online Sales
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Drug Class
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Latin America Dementia Associated with Alzheimer's Disease Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Class, 2017-2031
    • 12.2.1. Cholinergic/Cholinesterase (ChE) Inhibitors
    • 12.2.2. Memantine
    • 12.2.3. Combined Drugs (Memantine & Donepezil)
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail
    • 12.3.3. Online Sales
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Drug Class
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Dementia Associated with Alzheimer's Disease Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Class, 2017-2031
    • 13.2.1. Cholinergic/Cholinesterase (ChE) Inhibitors
    • 13.2.2. Memantine
    • 13.2.3. Combined Drugs (Memantine & Donepezil)
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.3.1. Hospital Pharmacies
    • 13.3.2. Retail
    • 13.3.3. Online Sales
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Drug Class
    • 13.5.2. By Distribution Channel
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. Merz Pharma
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Novartis AG
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. AbbVie Inc.
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Pfizer, Inc.
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Daiichi Sankyo Company, Limited.
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Ono Pharmaceutical Co., Ltd.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Johnson & Johnson Services, Inc.
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Eisai Co., Ltd.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. H. Lundbeck A/S
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. F. Hoffmann-La Roche Ltd.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview

List of Tables

  • Table 1: Global Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 2: Global Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 3: Global Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 4: North America Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 5: North America Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 6: North America Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 7: Europe Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 8: Europe Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 9: Europe Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Distribution Channel 2017-2031
  • Table 10: Asia Pacific Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Asia Pacific Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 12: Asia Pacific Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Latin America Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Latin America Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 15: Latin America Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Distribution Channel 2017-2031
  • Table 16: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 18: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, by Distribution Channel 2017-2031

List of Figures

  • Figure 1: Global Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 2: Global Dementia Associated with Alzheimer's Disease Market Value Share, by Drug Class, 2022
  • Figure 3: Global Dementia Associated with Alzheimer's Disease Market Value Share, by Distribution Channel, 2022
  • Figure 4: Global Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 5: Global Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 6: Global Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 7: Global Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 8: Global Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 9: Global Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 10: North America Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 11: North America Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 12: North America Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 13: North America Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 14: North America Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 15: North America Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 16: North America Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 17: Europe Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 18: Europe Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 19: Europe Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 20: Europe Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 21: Europe Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 22: Europe Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 23: Europe Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 24: Asia Pacific Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 25: Asia Pacific Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 26: Asia Pacific Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 27: Asia Pacific Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 28: Asia Pacific Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 29: Asia Pacific Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 30: Asia Pacific Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 31: Latin America Dementia Associated with Alzheimer's Disease Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 32: Latin America Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 33: Latin America Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Latin America Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 35: Latin America Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 36: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 37: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 39: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 40: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 41: Middle East & Africa Dementia Associated with Alzheimer's Disease Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 42: Global Dementia Associated with Alzheimer's Disease Market Share Analysis, by Company (2022)